SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-125222
Filing Date
2010-05-20
Accepted
2010-05-20 16:30:33
Documents
4
Period of Report
2010-05-16
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17931
2 PRESS RELEASE dex991.htm EX-99.1 9903
3 GRAPHIC g33181g18s68.jpg GRAPHIC 5180
4 GRAPHIC g33181g50p86.jpg GRAPHIC 3088
  Complete submission text file 0001193125-10-125222.txt   41092
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 10848233
SIC: 2834 Pharmaceutical Preparations